Cargando…

Experts’ Consensus on the Use of Pimecrolimus in Atopic Dermatitis in China: A TCS-Sparing Practical Approach

INTRODUCTION: Atopic dermatitis (AD) is a chronic, pruritic, inflammatory skin disease with rising prevalence. Topical corticosteroids (TCS) are recommended as first-line therapy for patients with AD in China; however, corticophobia is a widespread concern, which can manifest as noncompliance: in a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Zuotao, Gao, Xing-Hua, Li, Wei, Wang, Hua, Liang, Yunsheng, Tang, Jianping, Yao, Xu, Zhao, Hua, Luger, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021341/ https://www.ncbi.nlm.nih.gov/pubmed/35313362 http://dx.doi.org/10.1007/s13555-022-00696-z

Ejemplares similares

Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants
por: Luger, Thomas, et al.
Publicado: (2015)

Pimecrolimus for the Treatment of Atopic Dermatitis in Infants: An Asian Perspective
por: Chu, Chia-Yu, et al.
Publicado: (2023)

Treatment of atopic dermatitis with pimecrolimus – impact on quality of life
por: Lee, Hae-Hyuk, et al.
Publicado: (2007)

Formulary Review of Therapeutic Alternatives for Atopic Dermatitis: Focus on Pimecrolimus
por: Weinberg, Jeffery M.
Publicado: (2005)

Efficacy and tolerance of tacrolimus and pimecrolimus for atopic dermatitis: a meta-analysis
por: Yin, Zhiqiang, et al.
Publicado: (2011)

Is pimecrolimus cream (1%) an appropriate therapeutic agent for the treatment of external ear atopic dermatitis?
por: Beriat, Güçlü Kaan, et al.
Publicado: (2012)

Pimecrolimus Cream 1% in the Management of Atopic Dermatitis in Pediatric Patients: A Meta-Analysis
por: Huang, Chunyun, et al.
Publicado: (2014)

Pimecrolimus cream in the management of patients with atopic eczema
por: Spergel, Jonathan M
Publicado: (2009)

Retraction: Pimecrolimus Cream 1% in the Management of Atopic Dermatitis in Pediatric Patients: A Meta-Analysis
Publicado: (2014)

Pimecrolimus interferes the therapeutic efficacy of human mesenchymal stem cells in atopic dermatitis by regulating NFAT-COX2 signaling
por: Shin, Nari, et al.
Publicado: (2021)

Observational study of pimecrolimus 1% cream for prevention of transcutaneous sensitization in children with atopic dermatitis during their first year of life
por: Murashkin, Nikolay N., et al.
Publicado: (2023)

Guidelines on Management of Atopic Dermatitis in India: An Evidence-Based Review and an Expert Consensus
por: Rajagopalan, Murlidhar, et al.
Publicado: (2019)

Safety and efficacy of pimecrolimus versus vehicle for the treatment of atopic dermatitis in adults and paediatric population: a systematic review and meta-analysis
por: Akhtar, Sareema E., et al.
Publicado: (2023)

Burden of Disease, Unmet Needs in the Diagnosis and Management of Atopic Dermatitis: An Indian Expert Consensus
por: Rajagopalan, Murlidhar, et al.
Publicado: (2021)

Management of Atopic Dermatitis in Adults in Saudi Arabia: Consensus Recommendations from the Dermatological Expert Group
por: Alakeel, Abdullah, et al.
Publicado: (2022)

Expert consensus on the use of omalizumab in chronic urticaria in China()
por: Zhao, Zuotao, et al.
Publicado: (2021)

Consensus Update for Systemic Treatment of Atopic Dermatitis
por: Lee, Ji Hyun, et al.
Publicado: (2021)

The microbiome in patients with atopic dermatitis
por: Paller, Amy S., et al.
Publicado: (2018)

Consensus Conference on Clinical Management of pediatric Atopic Dermatitis
por: Galli, Elena, et al.
Publicado: (2016)

Clinical Features of Adult/Adolescent Atopic Dermatitis and Chinese Criteria for Atopic Dermatitis
por: Liu, Ping, et al.
Publicado: (2016)

Treatment of Facial Seborrheic Dermatitis with Pimecrolimus Cream 1%: An Open-Label Clinical Study in Korean Patients
por: Kim, Byung-Soo, et al.
Publicado: (2007)

The Efficacy and Safety of Pimecrolimus in Patients With Facial Seborrheic Dermatitis: A Systematic Review of Randomized Controlled Trials
por: Alsmeirat, Odeh, et al.
Publicado: (2022)

Prevalence and Clinical Features of Atopic Dermatitis in China
por: Wang, Xin, et al.
Publicado: (2016)

Potential Mechanisms of the Sparing of Atopic Dermatitis in the Diaper Region: A Scoping Review
por: Jazdarehee, Aria, et al.
Publicado: (2022)

Consensus on the therapeutic management of atopic dermatitis - Brazilian Society of Dermatology
por: Aoki, Valeria, et al.
Publicado: (2019)

National Saudi Consensus Statement on the Management of Atopic Dermatitis (2021)
por: Fatani, Mohammad I., et al.
Publicado: (2022)

Administrative Claims Analysis of Utilization and Costs of Care in Health Plan Members With Atopic Dermatitis Who Had Prior Use of a Topical Corticosteroid and Who Initiate Therapy With Pimecrolimus or Tacrolimus
por: Delea, Thomas E., et al.
Publicado: (2007)

Pimecrolimus increases the melanogenesis and migration of melanocytes in vitro
por: Xu, Ping, et al.
Publicado: (2017)

Health Plan Budget Impact Analysis for Pimecrolimus
por: Chang, Jane, et al.
Publicado: (2005)

Expert consensus on clinical research nurse management in China
por: Ge, Jieying, et al.
Publicado: (2023)

The Role of a Novel Generation of Emollients, ‘Emollients Plus’, in Atopic Dermatitis
por: Araviiskaia, Elena, et al.
Publicado: (2022)

Microneedling in Combination with Topical Pimecrolimus 1% versus Topical Pimecrolimus 1% for the Treatment of Refractory Stable Vitiligo: A Randomized Clinical Trial
por: Iraji, Fariba, et al.
Publicado: (2021)

Relationship between air pollution and childhood atopic dermatitis in Chongqing, China: A time-series analysis
por: Luo, Pan, et al.
Publicado: (2022)

Evidence - Based Pharmacological Treatment of Atopic Dermatitis: An Expert Opinion and New Expectations
por: Oranje, Arnold P
Publicado: (2014)

Systemic treatment of children and adolescents with atopic dermatitis aged ≥2 years: a Delphi consensus project mapping expert opinion in Northern Europe
por: de Graaf, M., et al.
Publicado: (2022)

Correlation between Triclosan (TCS) exposure and endometriosis
por: Ma, Kailai, et al.
Publicado: (2023)

Pimecrolimus 1% cream for anogenital lichen sclerosus in childhood
por: Boms, Stefanie, et al.
Publicado: (2004)

Successful Treatment of Cutaneous Lesions of Dermatomyositis with Topical Pimecrolimus
por: Kim, Ji Eun, et al.
Publicado: (2011)

Successful Treatment of Localized Pemphigus Foliaceus with Topical Pimecrolimus
por: Tyros, G., et al.
Publicado: (2013)

Practical Recommendations for the Topical Treatment of Atopic Dermatitis in South and East Asia
por: Luk, David, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k3202ftttc0geaeb5bkt552ap1